With no lysine kinase 1 in hepatic stellate cells promotes mouse and human liver fibrosis through glycolytic triosephosphate isomerase 1
Zeba Firdaus(Mayo Clinic), Enis Kostallari(Mayo Clinic in Arizona), David Pereyra(Mayo Clinic), Luke C. Doskey(Mayo Clinic), Gina L. Razidlo(Mayo Clinic), Shalil Khanal(WinnMed), Chou‐Long Huang(University of Iowa), Jasper K. Solverson(Mayo Clinic in Arizona), Julie Heimbach(Mayo Clinic), Timuçin Taner(Mayo Clinic), Patrick P. Starlinger(Mayo Clinic), Mehdi Yaqubi(Mayo Clinic), Vijay H. Shah(Mayo Clinic), Eugene W. Krueger(Mayo Clinic), Matthew J. Schellenberg(Mayo Clinic), Yang Xiao(Mayo Clinic), Alexander M. Washington(Mayo Clinic)
Cited by 0
Related Papers
Deficiency of terminal ADP‐ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease
|The EMBO Journal|2013|309
Recognition and maturation of effector RNAs in a CRISPR interference pathway
|Nature Structural & Molecular Biology|2011|166
Proteolytic Degradation of Topoisomerase II (Top2) Enables the Processing of Top2·DNA and Top2·RNA Covalent Complexes by Tyrosyl-DNA-Phosphodiesterase 2 (TDP2)
|Journal of Biological Chemistry|2014|120